Literature DB >> 18674659

Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate.

Sarah J Hemauer1, Ru Yan, Svetlana L Patrikeeva, Donald R Mattison, Gary D V Hankins, Mahmoud S Ahmed, Tatiana N Nanovskaya.   

Abstract

OBJECTIVE: Determine transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate and its distribution between the tissue and the maternal and fetal circuits of the dually perfused placental lobule. STUDY
DESIGN: 17-alpha-Hydroxyprogesterone caproate (21 ng/mL) and its dual-labeled isotope, 17-alpha-hydroxy-[(3)H] progesterone [(14)C] caproate were added to the maternal circuit. The concentrations of the drug and its metabolite in trophoblast tissue and both circuits were determined by high performance liquid chromatography and liquid scintillation spectrometry.
RESULTS: 17-alpha-Hydroxyprogesterone caproate was transferred from the maternal to fetal circuit. After a 4-hour perfusion period, a metabolite of 17-alpha-hydroxyprogesterone caproate that retained both progesterone and caproate moieties was identified in the tissue and the maternal and fetal circuits. Neither 17-alpha-hydroxyprogesterone caproate nor its metabolite, at the concentrations tested, had adverse effect on determined viability and functional parameters of placental tissue.
CONCLUSION: 17-alpha-Hydroxyprogesterone caproate was metabolized by term placental lobule during its perfusion and both parent compound and its metabolite(s) transferred to the fetal circuit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674659      PMCID: PMC4046337          DOI: 10.1016/j.ajog.2007.11.065

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Transplacental transfer and metabolism of buprenorphine.

Authors:  Tatiana Nanovskaya; Sujal Deshmukh; Monica Brooks; Mahmoud S Ahmed
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

2.  Metabolism of 17 alpha-hydroxyprogesterone-4-C14-17 alpha-caproate by homogenates of rat liver and human placenta.

Authors:  M WIENER; C I LUPU; E J PLOTZ
Journal:  Acta Endocrinol (Copenh)       Date:  1961-04

3.  Human placenta in vitro: characterization during 12 h of dual perfusion.

Authors:  R K Miller; P J Wier; D Maulik; P A di Sant'Agnese
Journal:  Contrib Gynecol Obstet       Date:  1985

4.  Bidirectional transfer of methadone across human placenta.

Authors:  Ilona A Nekhayeva; Tatiana N Nanovskaya; Sujal V Deshmukh; Olga L Zharikova; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2005-01-01       Impact factor: 5.858

5.  Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal function.

Authors:  M Onsrud; E Paus; E Haug; K Kjørstad
Journal:  Acta Obstet Gynecol Scand       Date:  1985       Impact factor: 3.636

6.  The effect of esterases on 17alpha-hydroxyprogesterone caproate.

Authors:  Ru Yan; Valentina Fokina; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Am J Obstet Gynecol       Date:  2007-10-22       Impact factor: 8.661

7.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

  7 in total
  18 in total

Review 1.  17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.

Authors:  Emma D Deeks
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

2.  Progesterone supplementation and the prevention of preterm birth.

Authors:  Errol R Norwitz; Aaron B Caughey
Journal:  Rev Obstet Gynecol       Date:  2011

3.  Metabolism of 17-alpha-hydroxyprogesterone caproate by human placental mitochondria.

Authors:  Valentina M Fokina; Olga L Zharikova; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Reprod Sci       Date:  2011-12-02       Impact factor: 3.060

Review 4.  Placental control of drug delivery.

Authors:  Sanaalarab Al-Enazy; Shariq Ali; Norah Albekairi; Marwa El-Tawil; Erik Rytting
Journal:  Adv Drug Deliv Rev       Date:  2016-08-12       Impact factor: 15.470

5.  Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation.

Authors:  Shringi Sharma; Steve Caritis; Gary Hankins; Menachem Miodovnik; Mary F Hebert; Don Mattison; Raman Venkataramanan
Journal:  Br J Clin Pharmacol       Date:  2016-07-13       Impact factor: 4.335

6.  Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.

Authors:  Steve N Caritis; Shringi Sharma; Raman Venkataramanan; Gary D Hankins; Menachem Miodovnik; Mary F Hebert; Jason G Umans; Thomas Benedetti; Donald Mattison; Anne Zajicek; Dawn Fischer; Aimee Jackson
Journal:  Am J Obstet Gynecol       Date:  2012-08-16       Impact factor: 8.661

7.  Developmental exposure to 17α-hydroxyprogesterone caproate impairs adult delayed reinforcement and reversal learning in male and female rats.

Authors:  Rebecka O Serpa; Christine K Wagner; Ruth I Wood
Journal:  J Neuroendocrinol       Date:  2020-06-02       Impact factor: 3.627

Review 8.  Basic obstetric pharmacology.

Authors:  Yang Zhao; Mary F Hebert; Raman Venkataramanan
Journal:  Semin Perinatol       Date:  2014-10-01       Impact factor: 3.300

9.  Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons.

Authors:  Ru Yan; Tatiana N Nanovskaya; Olga L Zharikova; Donald R Mattison; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2008-02-07       Impact factor: 5.858

10.  Bupropion metabolism by human placenta.

Authors:  Xiaoming Wang; Doaa R Abdelrahman; Olga L Zharikova; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Biochem Pharmacol       Date:  2010-01-28       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.